Today
Phil King’s Regal writes Opthea to zero and backs off risky bets
The veteran stockpicker told investors the firm would review how its $220 million wager on the biotech went so wrong “to ensure it does not occur again”.
Property pushes ASX up; Kelsian rallies
Shares advance; Kelsian looks to sell tourism division; MinRes served with class action; Amcor unveils CFO; Star’s $750 million lifeline fails; Pimco is bullish on Germany and China.
Investors are too calm on eve of Liberation Day
There are three ways Donald Trump’s announcement could go – and they would probably catch investors by surprise in some way, given current positioning.
Yesterday
Gold soars to $5000 in ‘once in 40-year gift’ for investors, fundies
The relentless rally has pushed the gold price almost 20 per cent higher this year, its best quarter since 1986. Money managers can see opportunities.
What bond managers expect from Trump’s tariffs
Australian bonds may be stuck in the middle of Trump’s trade war, but some fund managers expect the deteriorating growth outlook to spur a rally in bonds.
ASX closes up 1pc; RBA says no rate cut discussed
Shares rally as buyers step in; RBA holds cash rate at 4.1pc; Goodman jumps 2pc; RBC upgrades WiseTech; AVJennings snapped up for 65.5¢ a share; gold soars.
Liberation Day or Capitulation Day? Markets brace for pain
On the eve of Donald Trump’s big tariff announcement, investors are frantically trying to work out if enough bad news is priced in.
Former Goldman ECM boss Aaron Lamshed finds a new home
A 25-year veteran of the markets, Lamshed started at Goldman Sachs in 2014 and elevated to managing director in 2021.
4 charts reveal whether to cash out before ‘Liberation Day’
Warren Buffett, Li Ka-shing and Chanticleer emeritus Tony Boyd cashed up before Donald Trump’s next tariff announcement. Did they do the right thing?
KKR corrects a correction
It took KKR three tries to clear up the mess it made of its own ASX announcements.
March
Forget 60/40. Here’s Larry Fink’s new portfolio for a $108trn prize
The BlackRock boss says capitalism hasn’t failed, it just needs to help more people. And he thinks he knows how to achieve this.
Opthea in active talks with funders after second trial fails
The little hope left for Opthea shareholders has been crushed after the biotech said a second late-stage trial of its eye disease treatment had failed.
ASX wipes $42b on tariff fears; gold tops $US3100
ASX plummets in broad sell-off; gold at new highs; long-time WiseTech chair rejoins board; Todd Sampson exits Qantas; Domain board backs CoStar bid.
ASX’s $42b wipeout seals worst start to year since COVID crash
The local bourse has been swept up in the exodus on Wall Street as investors brace for Trump’s tariffs that could trigger a violent rotation out of risky assets.
RBA, ASIC say they are ‘increasingly concerned’ about ASX
The regulators said the market operator was not complying with risk mitigation standards after an outage in December left investors unable to settle trades.
The 5 big risks facing markets right now (that are not Donald Trump)
While the focus is on Donald Trump’s tariff announcement, investors are dealing with five big secular shifts, and a more pressing problem lurking.
This 5-minute test promises to make you a better investor
It’s never been easier to get a “money personality” assessment that offers to unlock your personal investing secrets. But is there any science to it?
These fundies outperformed this quarter thanks to gold and small caps
From the Trump administration’s tariff plans to the first rate cut in almost five years, it has been a turbulent three months. These investors have prospered.
Hedge fund veteran Michael Hintze on the rise of machines, and returns
It has been a year since the billionaire investor sold his storied London fund. Now he’s back with a new fund in the midst of a rapidly shifting market.
A trillion-dollar sovereign wealth fund could be Trump’s grandest plan
There are plenty of big assets that could be sold to get the White House’s hopes in motion. Investors are already being told not to underestimate the impact.